Lovenox and Foscavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovenox (enoxaparin sodium) and Foscavir (foscarnet sodium). Common drug interactions include eosinophilia among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Lovenox and Foscavir. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

What is Foscavir?

Foscavir has active ingredients of foscarnet sodium. eHealthMe is studying from 1,631 Foscavir users. Check the latest studies of Foscavir.



On Jul, 26, 2026

15 people who take Lovenox and Foscavir together, and have interactions are studied.

Lovenox and Foscavir drug interactions.

What are the common drug interactions of Lovenox and Foscavir, by gender? *:

female:

  1. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  2. Face oedema (swelling of face)
  3. Linear iga disease (a rare, idiopathic or drug-induced autoimmune blistering disease of skin)
  4. Pruritus (severe itching of the skin)
  5. Tongue oedema (swelling of tongue)
  6. Renal failure (kidney dysfunction)
  7. Renal failure acute (rapid kidney dysfunction)

male:

  1. Renal failure (kidney dysfunction)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Leukopenia (less number of white blood cells in blood)
  4. Lung transplant rejection (failure of lung transplant)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  7. Aplasia (defective development or congenital absence of an organ or tissue)
  8. Bone marrow failure
  9. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  10. Fungaemia (fungi circulate in the blood)

What are the common drug interactions of Lovenox and Foscavir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Renal failure (kidney dysfunction)
  2. Agitation (state of anxiety or nervous excitement)
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Confusional state
  5. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  6. Hallucination, visual (seeing things that aren't there)
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Anaemia (lack of blood)
  9. Iron deficiency
  10. Leukopenia (less number of white blood cells in blood)

60+:

  1. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  2. Face oedema (swelling of face)
  3. Fungaemia (fungi circulate in the blood)
  4. Linear iga disease (a rare, idiopathic or drug-induced autoimmune blistering disease of skin)
  5. Pruritus (severe itching of the skin)
  6. Tongue oedema (swelling of tongue)
  7. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Renal failure (kidney dysfunction)
  10. Bone marrow failure

What are the existing conditions these people have? *

  1. Cytomegalovirus Infection: 8 people, 53.33%
  2. Urticaria Chronic (long lasting rash of round, red welts on the skin that itch intensely): 3 people, 20.00%
  3. Haematotoxicity (toxins that destroy red blood cells): 3 people, 20.00%
  4. Pain: 2 people, 13.33%
  5. Immunodeficiency Disorders: 2 people, 13.33%
  6. Fungal Infection: 2 people, 13.33%
  7. Escherichia Bacteraemia (presence of bacteria escherichia coli in the blood): 2 people, 13.33%
  8. Dizziness: 2 people, 13.33%
  9. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 6.67%
  10. Septic Shock (shock due to blood infection): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lovenox and Foscavir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lovenox and Foscavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Foscavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Foscavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium and foscarnet sodium (the active ingredients of Lovenox and Foscavir, respectively), and Lovenox and Foscavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: